Global News Enterprises

Thomson Reuters Tax & Accounting in Boston offers a comprehensive suite of intelligence, technology, and human expertise to help individuals and businesses find trusted answers to their tax and accounting needs. With a focus on delivering reliable solutions, Thomson Reuters Tax & Accounting is dedicated to providing the tools necessary for informed decision-making in the complex world of taxation and financial management. Generated from their website's infomation

Alnylam Pharmaceuticals is a biopharmaceutical company. The company develops novel therapeutics based on the biological breakthrough known as ribonucleic acid interference. The company applies ribonucleic acid interference to address significant medical needs, many of which cannot effectively be addressed with small molecules or antibodies. This discovery enables the creation of a broad new class of human therapeutics. Alnylam Pharmaceuticals maintains partnerships with leading pharmaceutical and medical technology companies to drive further developments and capabilities. Major alliances include Merck, Medtronic and Novartis. Alnylam Pharmaceuticals, founded in 2002, maintains global headquarters in Cambridge, Mass., and has an additional operating unit in Kulmbach, Germany.